SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $971,000 | -81.7% | 5,307 | -84.1% | 1.05% | -80.9% |
| Q1 2019 | $5,302,000 | +1511.6% | 33,330 | +870.6% | 5.51% | +1323.3% |
| Q4 2018 | $329,000 | -72.3% | 3,434 | -59.2% | 0.39% | -59.0% |
| Q3 2018 | $1,187,000 | -78.4% | 8,408 | -76.1% | 0.94% | -78.3% |
| Q2 2018 | $5,505,000 | +59.2% | 35,174 | +63.8% | 4.36% | +67.2% |
| Q1 2018 | $3,459,000 | +226.3% | 21,477 | +234.0% | 2.61% | +270.2% |
| Q4 2017 | $1,060,000 | – | 6,431 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |